We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Reaches Into Neuro Space With Prothena Acquisition
Novo Nordisk Reaches Into Neuro Space With Prothena Acquisition
Novo Nordisk is exploring beyond its well-paved diabetes track, acquiring its first investigational neurological compound, PRX004, from Prothena in a deal potentially worth up to $1.2 billion.